KiroBlock

N/A

Report date: 2024/11/15 17:02:28
NME

Base Information

Drug NameKiroBlock
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsOvarian NeoplasmsColorectal NeoplasmsMultiple Myeloma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKiromic Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKiromic Biopharma Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsColorectal NeoplasmsMultiple Myeloma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A